Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the d dimer testing market right now?

In the past few years, the D dimer testing market has seen a steady increase in size. It is projected to expand from $1.47 billion in 2024 to reach $1.54 billion in 2025, growing at a Compound Annual Growth Rate (CAGR) of 5.0%. The growth seen during the historic period is credited to the progression of thrombosis research, enhancements in lab methodologies, clinical validation of the D-dimer as an important marker, and modifications in diagnostic protocols.

How fast Is the d dimer testing market expected to grow, and what’s its future value?

The market for D dimer testing is projected to experience substantial growth in the incoming years, and it’s predicted that it will increase to a worth of $1.9 billion by 2029, with a compound annual growth rate (CAGR) of 5.4%. The anticipated rise throughout this period can be ascribed to factors such as the escalation in the aging population, the expansion in point-of-care testing (POCT), assimilation with risk appraisal algorithms, heightened consciousness and educational campaigns, regulatory directions, and standardization. During this forecast period, the primary trends would include combinations of biomarkers for improved diagnoses, an emphasis on rapid, accurate outcomes, the use of d-dimer tests in the management of COVID-19, remote observation, home-based test kits, constant monitoring, and recurrent testing.

Get your d dimer testing market report here!

https://www.thebusinessresearchcompany.com/report/d-dimer-testing-global-market-report

What are the leading drivers of growth in the d dimer testing market?

The growing incidence of cancer is projected to spur the expansion of the d-dimer testing market in the future. Cancer falls into a class of diseases that can manifest in almost any organ or tissue when rogue cells multiply uncontrolled, defy their usual boundaries, and either metastasize to other organs or invade adjacent body parts. D-dimer testing chiefly assists in the diagnosis, monitoring, and treatment of cancer patients, as well as evaluating the possibility of blood clot creation. It tracks thrombotic occurrences in a range of clinical situations. For instance, per research published by the American Cancer Society, a health organization based in the US, in January 2022, the US is likely to witness 609,360 cancer-related deaths and 1.9 million fresh cases of cancer in 2022. This amounts to approximately 1,670 deaths daily. As a result, the escalating incidence of cancer is fueling the expansion of the d-dimer testing market.

What are the key segments defining the d dimer testing market?

The D dimer testing market covered in this report is segmented –

1) By Test: Clinical Laboratory Tests, Point-Of-Care Tests

2) By Product: Analyzers, Reagents And Consumables

3) By Method: Enzyme-linked Immunosorbent Assay (ELISA), Latex-enhanced Immuno-turbidimetric Assays, Fluorescence Immunoassays, Other Testing Method

4) By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Other Application

5) By End-User: Hospitals, Academic And Research Institutes, Diagnostic Centers, Other End-User

Subsegments:

1) By Clinical Laboratory Tests: Enzyme-Linked Immunosorbent Assay (Elisa), Chemiluminescent Immunoassay (CLIA), Latex Agglutination Assays, Other Laboratory Testing Methods

2) By Point-Of-Care Tests: Rapid Test Kits, Portable Testing Devices, Lateral Flow Assays, Other Point-Of-Care Testing Methods

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12341&type=smp

Who are the key players steering the development of the d dimer testing market?

Major companies operating in the D dimer testing market include Kaiser Foundation Health Plan Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson And Company (BD), Laboratory Corporation, Quest Diagnostics Inc., bioMérieux SA, Beckman Coulter Inc., Quidel Corporation, QuidelOrtho Corporation, Sysmex Corporation, Horiba Ltd., Werfen SA, Helena Laboratories Corporation, Abcam plc, LumiraDx Limited, Personalabs, Sekisui Diagnostics LLC, Diagnostica Stago S.A.S., RayBiotech Inc., CTK Biotech Inc., Diazyme Laboratories Inc., AdvaCare Pharma USA, UCP Biosciences Inc., AccuBioTech Co Ltd., Response Biomedical Corporation

What emerging trends are influencing the growth of the d dimer testing market?

Key players in the D-dimer testing market are engaging in strategic alliances to secure exclusive privileges to D-dimer testing solutions, thereby strengthening their competitive stance in the market. Such alliances involve exploiting each other’s capabilities and assets in order to drive mutual growth and success. A case in point is the collaboration in March 2022 between SphingoTec GmbH, a biotechnology firm based in Germany, and Rivaara Labs Private Limited, an Indian-based medical laboratory and healthcare firm. As a result of this collaboration, Rivaara earned exclusive rights to promote and disperse SphingoTec’s point-of-care tests featuring groundbreaking markers across the Indian subcontinent. These include the proenkephalin (penKid) for kidney functionality evaluation, bioactive adrenomedullin (bio-ADM) for assessing endothelial function, and dipeptidyl peptidase 3 (DPP3) as cardiac depression indicators. These cutting-edge markers are backed by familiar parameters such as procalcitonin, troponin, D-dimer, NT-proBNP, and TSH.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12341

Which regions are most influential in expanding the d dimer testing market?

North America was the largest region in the D dimer testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the D dimer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Drugs of Abuse (DOA) Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drugs-of-abuse-doa-testing-global-market-report

Minimal Residual Disease Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/minimal-residual-disease-testing-global-market-report

Laboratory Testing Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/laboratory-testing-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: